4//SEC Filing
Oliveto Joseph 4
Accession 0001209191-20-035116
CIK 0001408443other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 7:05 PM ET
Size
9.7 KB
Accession
0001209191-20-035116
Insider Transaction Report
Form 4
Oliveto Joseph
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Shares
2019-12-21$1.54/sh+7,400$11,396→ 280,555 total - Award
Employee Stock Option (right to buy)
2020-06-05+150,000→ 150,000 totalExercise: $3.74Exp: 2030-06-05→ Common Shares (150,000 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2019-12-21−7,400→ 113,856 totalExercise: $1.54Exp: 2027-12-12→ Common Shares (7,400 underlying)
Footnotes (2)
- [F1]The original grant was for 252,853 option shares. Twenty-five percent (25%) of the shares subject to the option vested on September 19, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]The shares subject to this option shall vest in twenty-four (24) equal monthly installments commencing on July 5, 2020, subject to the recipient continuing to provide service to the Issuer through each such date.
Documents
Issuer
Milestone Pharmaceuticals Inc.
CIK 0001408443
Entity typeother
Related Parties
1- filerCIK 0001437782
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 7:05 PM ET
- Size
- 9.7 KB